Skip to Main Content

Paper Details

Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma.
Clin Cancer Res
13
2021
Author NameAffiliation
Keren IsaevPrincess Margaret Cancer Centre, University Health Network
Housheng Hansen HePrincess Margaret Cancer Centre, University Health Network
Housheng Hansen HeUniversity of Toronto
Lauren C Chong
David W Scott
  • 1 - 5

Datasets

Release 1.2